Intern, Commercial MBA Leadership Development Program Internship (Summer 2026) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

InternshipExperience Level

InternshipJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Enrolled in a Master of Business Administration (MBA) degree program during the current school year (graduating Spring of 2027)
All candidates must be authorized to work in the US at the time of hire (no immigration or visa sponsorship available)
Minimum 3 years of work experience preferred, but not mandatory
Experience in marketing, sales and/or healthcare/pharmaceutical industry preferred, but not mandatory
Demonstrated leadership in student, community, or professional organizations
The ability to gather, analyze and translate data to gain a deeper understanding of the customer, brand, disease area, market, and competition
Ability to lead without authority and possess strong project management capabilities
Diverse thinking with innovative ideas and new approaches to maximize opportunities

Responsibilities

Contribute meaningfully to teams through challenging assignments and collaborate with Commercial leaders and other key stakeholders
Work on impactful projects relevant to current business needs, such as developing and launching new sales force promotional materials
Collaborate with global markets to inform strategy for future clinical trials and launches
Translate data insights to create new patient education resources
Participate in an introduction to brand planning and marketing excellence in the biopharma industry
Attend speaker series with senior leaders on key biopharma business topics and various career paths at BMS
Engage in formal mentorship with commercial leaders and current full-time CLDP associates
Participate in teambuilding and networking events
Deliver a final presentation to senior leaders and team members on summer projects

Skills

Marketing

Sales

Commercialization

Business Insights

Market Access

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free